OHE Presentations at HTAi: Tokyo 2016

The 2016 HTAi Annual Meeting was held in Tokyo, Japan, 10-14 May 2016. The focus of the meeting was Informing Health Care Decisions with Values and Evidence. This post contains presentations given by the OHE team.

The 2016 HTAi Annual Meeting was held in Tokyo, Japan, 10-14 May 2016. The focus of the meeting was Informing Health Care Decisions with Values and Evidence. Several members of the OHE team attended and contributed to the conference. This post contains presentations by the OHE team.

Dimensions of Value, Assessment, and Decision Making by Adrian Towse

In a Breakfast Symposium, Adrian Towse presented on “Dimensions of Value, Assessment, and Decision Making” setting out a framework for (i) Identifying the elements of value (ii) the use of categories or discrete scales to rate / value these elements (iii) how to weight and aggregate these elements to arrive at a “decision on value” and (iv) translation to price and affordability using cost-effectiveness or therapeutic added value approaches.

How can HTA’s in Asia respond to Increased Clinical Uncertainty: the potential for PBRSAs by Adrian Towse

Adrian Towse presented in a Panel entitled “How can HTA’s in Asia respond to Increased Clinical Uncertainty?” on the  potential for using risk Sharing Agreements, looking at how to implement risk sharing and managed entry agreements, examining case studies and international best practice, identifying barriers and opportunities.

Making Value-Based Pricing a Reality – the Case for Multi-Indication Pricing by Adrian Towse

In a lunch time Symposium, Adrian Towse presented on “Making Value-Based Pricing a Reality – the Case for Multi-Indication Pricing”.

Operationalising Value-based Pricing: Do we know what we value and what we are giving up to get it? by Adrian Towse

In a Panel Session Adrian Towse presented on “Operationalising Value-based Pricing: Do we know what we Value and What we are giving up to get it?” in which he focussed on the evidence in the UK on the opportunity cost of NICE decisions, looking at the Claxton et al. work, the Barnsley et al critique, and work by Karlsberg Schaffer et al. on Wales and on Scotland.

Availability, Accessibility and Applicability of Evidence: Transferability – Data Versus Pragmatism by Adrian Towse

In a Panel entitled “Data Versus Pragmatism in the Decision Making Process” Adrian Towse presented on the Transferability of Evidence, highlighting three innovative approaches from OHE authors.

Options for Formulary Development in Middle-Income Countries by Karla Hernandez-Villafuerte

Options for Formulary Development in Middle-Income Countries by Karla Hernandez-Villafuerte A number of middle-income countries (MICs) are evolving their health systems toward universal health coverage for patient populations. Such countries often have limited drug formularies and some form of essential drugs list. This presentation explores options for bridging the organisation of the health system and its priorities, and provides a framework for developing drug formularies.

Health Economic Evaluation of Bibliometric Trends in Sub-Saharan Africa by Karla Hernandez-Villafuerte 

Collaboration between Sub-Saharan African researchers is important in the generation and transfer of evidence to support the decision making process for health priority setting. This presentation provides an evaluation of collaboration patterns between countries. 

Structured decision making approaches to the inclusion of multiple criteria in HTA by Nancy Devlin Multiple criteria are already used in HTA – so the question isn’t whether to employ multiple criteria, but how this is best done. OHE’s Professor Devlin presented on “structured decision making approaches to the inclusion of multiple criteria in HTA.”